Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Fibroblast growth factor receptor (FGFR) |
Target Info
|
Antagonist |
[2] |
| Fusion protein FGFR3-TACC3 (FGFR3-TACC3) |
Target Info
|
Inhibitor |
[1] |
| Proto-oncogene c-Src (SRC) |
Target Info
|
Inhibitor |
[3] |
| References |
Top |
| REF 1 |
Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma.Cancer Biol Ther. 2014;15(12):1613-21.
|
| REF 2 |
Tumor angiogenesis as a therapeutic target. Drug Discov Today. 2001 Oct 1;6(19):1005-1024.
|
| REF 3 |
Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy. Invest New Drugs. 1999;17(2):121-35.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
